How long does Wegovy start to work — and what should you expect?

What the STEP 1 trial data actually show about early response

The STEP 1 trial is the bedrock of what we know about semaglutide's timeline. At 68 weeks, participants on 2.4mg semaglutide lost on average around 15% of body weight compared with roughly 2.4% for those on placebo, alongside lifestyle support. That headline figure, cited by NICE in its recommendation of semaglutide (TA875), represents the accumulated effect of a full treatment course, not what week four looks like.

In the trial, weight loss was steepest during the active titration phase, as doses climbed from 0.25mg through 0.5mg, 1mg, 1.7mg to the 2.4mg maintenance dose. Once maintenance was reached, the curve continued downward but more gradually. That pattern matters practically: the first few weeks are about tolerability and adjustment, not transformation.

Early signals are still real, though. Reduced hunger and a feeling of fullness arriving sooner at meals are reported by many people within the first week or two, and if you want to understand how fast Wegovy starts working in those opening days, the mechanisms involved give a clearer picture than the scales alone. A simple habit worth building from week one: weigh yourself on the same day each week, at the same time of day, and note it down. One data point tells you little; eight in a row tells a story.

Why the titration schedule shapes the timeline

Wegovy's dosing schedule exists for a reason. Treatment opens at 0.25mg weekly, a level chosen to let the body adapt, not to drive weight loss. Each step up happens roughly every four weeks, guided by the prescriber. The 2.4mg maintenance dose, where the full therapeutic effect is reached, typically arrives around month five for people who tolerate each increase without difficulty.

This is important context for managing expectations. If you want to understand how fast Wegovy starts to work and compare it to your own experience at week three, the comparison may not be fair, you may still be several dose steps away from the level studied in the trials. For a fuller picture of the semaglutide timeline from a standing start, the semaglutide timeline page covers the full titration arc in detail.

At nume (sorry, at no) at nume, every dose change is reviewed by a GPhC-registered prescriber before it happens. That review looks at how you've responded so far and whether it is clinically appropriate to move up. There is no automated escalation. Details of how that process works are on the about us page.

When to expect noticeable results, and what affects the pace

Clinical guidance and trial data together suggest a rough practical timeline: reduced appetite in weeks one to four; early weight change (often 1–3kg) by weeks four to eight; more consistent loss from weeks eight to sixteen as the dose climbs; and the bulk of the total effect accumulating between months four and eighteen. For anyone asking how long Wegovy takes to work, the dedicated timeline page maps this out week by week.

Several factors shift the pace for individuals. Starting weight matters, people with higher baseline BMIs often see larger absolute reductions early on. Dietary changes made alongside treatment amplify the effect; semaglutide reduces appetite, but the quality of what you eat still shapes outcomes. Activity level, sleep, and whether any underlying conditions are present all play a role too.

If you're considering what Wegovy costs as part of planning a treatment course, the Wegovy price page sets out what a private prescription typically includes in the UK. Broader information about weight-loss treatment options is on the weight-loss treatments overview.

Side effects in the early weeks and what they mean for progress

Nausea, loose stools, constipation, indigestion and fatigue are the side effects most commonly reported in the first weeks of treatment, and they're well-documented in the NHS's guidance on semaglutide. For most people they are mild to moderate and settle as the body adjusts, typically within a few days to two weeks at each new dose level.

These early GI effects can be discouraging, especially when weight loss is not yet visible. It helps to know that they are usually a sign the medicine is active, not a sign something has gone wrong. Eating smaller portions, avoiding high-fat meals, staying well hydrated and not lying down immediately after eating are practical steps that many people find reduce the worst of it. If symptoms are severe or persist, contact your prescriber, dose timing or the pace of titration can sometimes be adjusted.

Our clinical team, led by our clinical lead, is available seven days a week for aftercare questions. That access matters most in these first weeks when questions tend to come up most often.